TABLE 4.
Cumulative incidence of diseases associated with >1% cholestasis in infancy
| Diagnosis | N | per 10,000 | 1 in “x” | Cholestatic† |
|---|---|---|---|---|
| Bliary tract disorders | 81 | 3.0 | 1 in 3348 | 63.0% |
| Biliary atresia | 27 | 1.0 | 1 in 10040 | 100.0% |
| Liver diseases | 142 | 5.2 | 1 in 1910 | 35.2% |
| Viral hepatitides | 26 | 1.0 | 1 in 10428 | 30.8% |
| Gastrointestinal disorders | 706 | 26.0 | 1 in 384 | 5.1% |
| Intestinal atresia | 143 | 5.3 | 1 in 1896 | 4.9% |
| Hirschsprung’s disease | 76 | 2.8 | 1 in 3568 | 1.3% |
| Metabolic disorders | 334 | 12.3 | 1 in 812 | 3.6% |
| Down’s Syndrome | 259 | 9.6 | 1 in 1047 | 3.5% |
| Severe bacterial infections | 2152 | 79.4 | 1 in 126 | 1.3% |
Cholestatic refers to subjects with a maximum CB ≥2 mg/dL or DB ≥5 mg/dL in their 1st year after birth